MEGA: Expect Growth Rate to Slow Down in 2022
We maintain BUY rating and roll over target price to Bt56 (+8% from previous TP) based on 25xPE’22E, a 15% discount from Thai health care peers.
325 Views
MEGA: 3Q18 Result Is Slightly Below Our Expectation
MEGA reported 3Q18 net profit of Bt255m (+4%YoY, -12%QoQ). 9M18 result accounts for 63% of our full year forecast and is slightly below our...
529 Views
MEGA: Supplement Maker Spreads Healthy Message in Booming Region
We initiate coverage on MEGA with a BUY rating and based on a target price of Bt43, which is derived from the DCF methodology (WACC 12.5% and...
575 Views